Literature DB >> 7508935

Activation of receptor-associated tyrosine kinase JAK2 by prolactin.

H Rui1, R A Kirken, W L Farrar.   

Abstract

JAK family tyrosine kinases have recently been implicated in intracellular signal transduction by transmembrane cytokine receptors of the interferon (IFN) and hematopoietin receptor families. Using the prolactin (PRL)-dependent rat pre-T cell line Nb2, a PRL receptor-associated, candidate tyrosine kinase of 120-130 kDa was recently characterized (1). In the present work this protein is identified as JAK2, based upon reciprocal anti-JAK2 and anti-phosphotyrosine immunoprecipitation and immunoblotting. JAK2 underwent rapid and transient tyrosine phosphorylation in response to receptor activation, reaching peak levels within 5 min of exposure to 100 nM PRL at 37 degrees C. In vitro tyrosine kinase assays using either [gamma-32P]ATP and autoradiography or unlabeled ATP combined with anti-phosphotyrosine immunoblotting, demonstrated that the activity of JAK2 was stimulated by PRL. Phosphoamino acid analysis of JAK2 after in vitro tyrosine kinase assay revealed that the majority of phosphate was incorporated into tyrosine residues. Furthermore, JAK2 was associated with PRL receptors to a comparable extent before and after PRL binding, as demonstrated by anti-receptor immunoprecipitation and subsequent anti-JAK2 immunoblotting. We propose that binding of ligand to the PRL receptor activates preassociated JAK2, and that this enzyme generates the initial signal in the intracellular communication cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508935

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 3.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

4.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

5.  Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.

Authors:  Yunfei Wen; Ying Wang; Anca Chelariu-Raicu; Elaine Stur; Yuan Liu; Sara Corvigno; Faith Bartsch; Lauren Redfern; Behrouz Zand; Yu Kang; Jinsong Liu; Keith Baggerly; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-07-31       Impact factor: 6.261

6.  Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.

Authors:  K C Gilmour; R Pine; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Expression cloning of a cDNA encoding a fish prolactin receptor.

Authors:  O Sandra; F Sohm; A de Luze; P Prunet; M Edery; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 8.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

9.  Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

Authors:  K D O'Neal; M V Chari; C H Mcdonald; R G Cook; L Y Yu-Lee; J D Morrisett; W T Shearer
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation.

Authors:  B Rodríguez-Liñares; S P Watson
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.